Atlantic Edge Private Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.35K Hold
193
– – ﹤0.01% 455
2026
Q2
$9.08K Hold
193
– – ﹤0.01% 433
2026
Q1
$3.65K Hold
193
– – ﹤0.01% 489
2025
Q4
$2.58K Hold
193
– – ﹤0.01% 508
2025
Q3
$2.28K Hold
193
– – ﹤0.01% 492
2025
Q2
$1.25K Hold
193
– – ﹤0.01% 485
2025
Q1
$1.13K Buy
+193
New +$1.38K ﹤0.01% 474

Other funds holding DFTX

Atlantic Edge Private Wealth Management's DFTX Position: Q3 2026 in Review

Atlantic Edge Private Wealth Management held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 193 shares worth $7.35K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Atlantic Edge Private Wealth Management first reported a position in DFTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $9.08K in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Atlantic Edge Private Wealth Management held 193 shares of Definium Therapeutics worth $7.35K as of Q3 2026.
  • Atlantic Edge Private Wealth Management left its Definium Therapeutics share count unchanged in Q3 2026.
  • Definium Therapeutics made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q3 2026, its #455 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Atlantic Edge Private Wealth Management's Definium Therapeutics position peaked at $9.08K in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.